Vanda Pharmaceuticals Inc (VNDA): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 11,5 US Dollar | 4 | 0 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 60.462.687 | 14,42 | 7,56 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Vanda Pharmaceuticals Inc
Mitarbeiter 533
Handelsplatz NASDAQ
Ticker Symbol VNDA
IPO Datum 2006-04-12
Adresse 2200 Pennsylvania Avenue NW, Washington, DC, United States, 20037
Webseite https://www.vandapharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Mihael H. Polymeropoulos M.D. | Founder, President, CEO & Chairman of The Board |
| 2 | Mr. Kevin Patrick Moran | Senior VP, CFO & Treasurer |
| 3 | Mr. Joakim Wijkstrom | Senior VP & Chief Marketing Officer |
| 4 | Mr. Gunther Birznieks | Senior Vice President of Business Development |
| 5 | Mr. Daniel Patrick McGuire | Senior VP, General Counsel & Secretary |
| 6 | Mr. Scott L. Howell | Chief People Officer |
| 7 | Mr. Christos Polymeropoulos M.D. | Senior Vice President & Medical Director |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 12,66% | 30,62 Mio. USD |
| 2 | State Street Corp | 5,82% | 14,07 Mio. USD |
| 3 | AQR Capital Management LLC | 5,78% | 13,99 Mio. USD |
| 4 | Renaissance Technologies Corp | 5,69% | 13,77 Mio. USD |
| 5 | Vanguard Capital Management, LLC | 4,17% | 10,10 Mio. USD |
| 6 | AIGH Capital Management, LLC | 3,38% | 8,18 Mio. USD |
| 7 | Acadian Asset Management LLC | 3,17% | 7,67 Mio. USD |
| 8 | Dimensional Fund Advisors, Inc. | 2,86% | 6,91 Mio. USD |
| 9 | Millennium Management LLC | 2,65% | 6,41 Mio. USD |
| 10 | Geode Capital Management, LLC | 2,45% | 5,94 Mio. USD |
| 11 | Two Sigma Investments LLC | 2,23% | 5,40 Mio. USD |
| 12 | Marshall Wace Asset Management Ltd | 2,03% | 4,90 Mio. USD |
| 13 | Jacobs Levy Equity Management, Inc. | 2,01% | 4,85 Mio. USD |
| 14 | Krensavage Asset Management, LLC | 1,95% | 4,72 Mio. USD |
| 15 | Vanguard Portfolio Management, LLC | 1,87% | 4,52 Mio. USD |
| 16 | The Goldman Sachs Group Inc | 1,71% | 4,15 Mio. USD |
| 17 | Citadel Advisors Llc | 1,25% | 3,03 Mio. USD |
| 18 | Qube Research & Technologies | 1,21% | 2,92 Mio. USD |
| 19 | Federated Hermes Inc | 1,18% | 2,86 Mio. USD |
| 20 | Charles Schwab Investment Management Inc | 1,07% | 2,59 Mio. USD |